be discarded. Nevertheless, beyond these results in cardiology, no author has argued that it is impossible to rely on hormesis to improve healthspan in human beings. Therefore, all authors have provided the same answer to the question "Is hormesis applicable as a pro-healthy aging intervention in mammals and human beings?" and this answer is "Yes".
Most authors consider that answering to the second part of the question ("and how?") will not be an easy thing. The devil is in the details, because using a mild stress in human beings is a source of many ethical and practical questions. Most articles in the present issue have emphasized that a stress can be "mild" (favorable effects?) for a given individual or "strong" (deleterious effects) for another one (see e.g. Rattan and Demirovic 2010) . In addition, a stress can be a mild one at one age and a strong one later in life and we probably cannot perform the experiment to know whether it were strong, for obvious ethical reasons. A mild stress could also become a strong one if used in people already subjected to another stress (see Sørensen et al. 2010) . The basic questions are thus: what mild stress could be used, when, with what dose?
Answering to the first question seems to be rather easy: exercise is probably the best candidate (see e.g., Marques et al. 2010 , Pardon 2010 , but heat stress is another one (e.g., Le Bourg 2010 , Vaiserman 2010 ). It has also been argued that chemicals (see Hayes 2010) could be a nutritional stimulus with favorable effects. Yet, this is a short list of stresses and the imagination of scientists is strongly required to discover new mild stresses in human beings.
Answering to "When" using a mild stress will make sense probably after a mild stress had been selected. Anyway, we should already try to answer to the following question: should we apply the mild stress at a young age, as in experimental models, or only at old age? It will be probably hard to convince young people to engage in a "mild stress" therapy in the hope to improve their life when old. Elderly people would probably be more easily convinced, but would a mild stress still be efficient at this age (Abete et al. 2010) ?
Finally, the question "What dose?" is dependent on the answer to the previous questions. Unfortunately, we will probably have to answer all these questions at the same moment. Taking into account all these problems, Kahn and Olsen (2010) stress that "it is more likely that hormetic therapy will become popular as treatment when used as an adjunct to other treatment strategies for serious illnesses", rather than in "normal healthy individuals". The other authors may probably consider this view as a little pessimistic one.
Therefore, the road towards using mild stress in human beings is probably more like a dirt track with many ruts than like a highway. It is the hope of the guest editors that the present debate among experts will provoke new studies on the use of hormesis in human beings. É. Le Bourg and S. I. S. Rattan 
